Author
Listed:
- B.E. Riley
(Elan Pharmaceuticals)
- J.C. Lougheed
(Elan Pharmaceuticals)
- K. Callaway
(Elan Pharmaceuticals)
- M. Velasquez
(Elan Pharmaceuticals)
- E. Brecht
(Elan Pharmaceuticals)
- L. Nguyen
(Elan Pharmaceuticals)
- T. Shaler
(SRI International)
- D. Walker
(Elan Pharmaceuticals)
- Y. Yang
(Elan Pharmaceuticals)
- K. Regnstrom
(Elan Pharmaceuticals)
- L. Diep
(Elan Pharmaceuticals)
- Z. Zhang
(Elan Pharmaceuticals)
- S. Chiou
(Elan Pharmaceuticals)
- M. Bova
(Elan Pharmaceuticals)
- D.R. Artis
(Elan Pharmaceuticals)
- N. Yao
(Elan Pharmaceuticals)
- J. Baker
(Elan Pharmaceuticals)
- T. Yednock
(Elan Pharmaceuticals)
- J.A. Johnston
(Elan Pharmaceuticals)
Abstract
Parkin is a RING-between-RING E3 ligase that functions in the covalent attachment of ubiquitin to specific substrates, and mutations in Parkin are linked to Parkinson’s disease, cancer and mycobacterial infection. The RING-between-RING family of E3 ligases are suggested to function with a canonical RING domain and a catalytic cysteine residue usually restricted to HECT E3 ligases, thus termed ‘RING/HECT hybrid’ enzymes. Here we present the 1.58 Å structure of Parkin-R0RBR, revealing the fold architecture for the four RING domains, and several unpredicted interfaces. Examination of the Parkin active site suggests a catalytic network consisting of C431 and H433. In cells, mutation of C431 eliminates Parkin-catalysed degradation of mitochondria, and capture of an ubiquitin oxyester confirms C431 as Parkin’s cellular active site. Our data confirm that Parkin is a RING/HECT hybrid, and provide the first crystal structure of an RING-between-RING E3 ligase at atomic resolution, providing insight into this disease-related protein.
Suggested Citation
B.E. Riley & J.C. Lougheed & K. Callaway & M. Velasquez & E. Brecht & L. Nguyen & T. Shaler & D. Walker & Y. Yang & K. Regnstrom & L. Diep & Z. Zhang & S. Chiou & M. Bova & D.R. Artis & N. Yao & J. Ba, 2013.
"Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases,"
Nature Communications, Nature, vol. 4(1), pages 1-9, October.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2982
DOI: 10.1038/ncomms2982
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms2982. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.